 VALENCIA, Calif. and MELBOURNE, Australia, April 28, 2022 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it will release its first quarter 2022 financial results on Thursday, May 12, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time Friday, May 13, 2022 at 6:30 a.m. Australian Eastern Standard Time to discuss its financial results and recent highlights. 